Karol E. Watson, MD, PhD, is Professor of Medicine/Cardiology and the John C. Mazziotta Term Chair in Medicine at the Geffen School of Medicine at UCLA. She was honored to be named Cardiologist of the Year, by the California chapter of the American College of Cardiology (ACC) for 2017-18 and she was recipient of the ACC Bernadine Healy Leadership in Women’s CV Disease Award. Dr. Watson is director of the UCLA Barbra Streisand Women’s Heart Health Program, Co- Director of the UCLA Program in Preventative Cardiology, and director of the UCLA Cardiology Fellowship. She is a Principal Investigator for several large NIH studies and her research focuses on prevention of heart disease, vascular calcification, hypertension, hypercholesterolemia, and cardiovascular disparities.

Dr. Watson declares sources of funding and relationships with the following commercial stakeholders in the healthcare sector: Boehringer Ingelheim, Amarin, Amgen, Novartis, Eli Lilly